Clinical Trial Update: A Study Investigating the Efficacy and Safety of Intravitreal (IVT) Injections of Vonaprument (Formerly ANX007) in Participants With Geographic Atrophy (GA) [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating intravitreal vonaprument for geographic atrophy is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Geographic Atrophy

Drugs mentioned

• Vonaprument (vonaprument)

Snippet

Sponsor: Annexon, Inc. | Conditions: Geographic Atrophy | Phase 3 | Status: ACTIVE_NOT_RECRUITING